Author Archives: admin


Venturis Clinic Now Offering Complimentary Webinar on the Benefits of Amniotic Stem Cell Therapy – Benzinga

Venturis Clinic is now offering a complimentary webinar to anyone interested in learning more about amniotic stem cell therapy. Attendance is online and available from anywhere, with the webinar occurring on June 27th.

Oklahoma City, OK (PRWEB) June 26, 2017

Venturis Clinic is now offering a free webinar titled "The 411 on Avoiding Surgery with Amniotic Stem Cell Therapy." The webinar is scheduled for Tuesday, June 27th at 8:00 PM EST (5:00 PM PST). Anyone can participate virtually by signing up at https://r3stemcell.com/patient-webinar-signup with a special offer being available to all attendees.

The webinar will be hosted by R3 Stem Cell CEO David Greene, MD, MBA. Venturis Clinic is an R3 Center of Excellence, offering the amniotic stem cell procedures with Board Certified providers affiliated with the University of Oklahoma.

Venturis Clinic has performed an exceptional amount of the nonoperative regenerative medicine procedures, and helped many patients avoid the need for potentially risky surgery. Treatment with amniotic stem cell therapy is available in both Oklahoma City and Tulsa.

There is no charge for the webinar, and viewers will receive a significant special bonus offer at the end. The webinar is easily viewable on one's computer using the link sent after registering. During the live webinar, individuals will be able to ask questions.

Topics covered will include FAQ's, cell counts with amniotic therapy, insurance coverage, IRB research, outcomes with the treatment, comparisons to other methods and much more. People will be educated consumers after viewing the webinar, which will also be available on replay afterwards as well.

For those who would like to sign up for the FREE Webinar: The 411 on Amniotic Stem Cell Treatment simply visit the link above. To schedule appointments with Venturis Clinic for a free consultation, call (844) GET-STEM.

For the original version on PRWeb visit: http://www.prweb.com/releases/2017/06/prweb14458844.htm

More:
Venturis Clinic Now Offering Complimentary Webinar on the Benefits of Amniotic Stem Cell Therapy - Benzinga

Existing Drug Found to be Effective at Killing Cancer Stem Cells – Technology Networks

Researchers experiment with the Sam68 protein. Credit: McMaster University

A team of researchers at McMaster University has identified a unique feature of cancer stem cells that can be exploited to kill the deadly cells thought to be the reason that cancer comes back after therapy. Understanding this feature will be useful for delivering more targeted cancer therapeutics to the right patients.

The study, published today in the scientific journal Cell Chemical Biology, reveals that an existing set of drugs is effective in killing cancer stem cells and explains how this led the team to uncovering important details about how these cells are working in human tumors.

"The drugs helped us to understand the biology," said Mick Bhatia, principal investigator of the study and scientific director of the McMaster Stem Cell and Cancer Research Institute. "We've worked backwards, employing a series of drugs used in the clinic to understand a new way that cancer stem cells can be killed."

The researchers found that a particular protein, called Sam68, is an important actor in cancer stem cells, and that this protein allows existing drugs to work on cancer cells, causing them to die.

Bhatia hopes that this information can be used to deliver targeted therapies to the patients who would benefit from them, while sparing others from unhelpful treatments. He believes that treatment of blood cancers like leukemia and other cancers such as prostate, colon and renal will follow the example set in breast cancer, where patients receive treatments tailored to their specific form of the disease.

"In the case of breast cancer, other researchers have found new ways to make existing drugs more effective by only giving them to people who were likely to benefit based on their specific traits and using drugs that target these traits," Bhatia said.

He said while developing a new drug takes an average of about 15 years and comes with a price tag in the hundreds of millions, defining the role of existing drugs to use them better in patients will help to accelerate the process of bringing the right drugs to the right people.

Reference

Mickie Bhatia et al. Sam68 Allows Selective Targeting of Human Cancer Stem Cells. Cell Chemical Biology, June 2017 DOI: 10.1016/j.chembiol.2017.05.026

See the original post here:
Existing Drug Found to be Effective at Killing Cancer Stem Cells - Technology Networks

Large-scale production of living brain cells enables entirely new research – Medical Xpress

June 26, 2017

Important pieces of the puzzle to understand what drives diseases such as Alzheimer's and Parkinson's are still missing today. One crucial obstacle for researchers is that it is impossible to examine a living brain cell in someone who is affected by the disease. With the help of a new method for cell conversion, researchers at Lund University in Sweden have found a way to produce diseased, aging brain cells on a large scale in a cell culture dish.

After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient. The fact that the cells can now be produced in large quantities enables researchers to carry out a series of experiments that were previously not possible.

A few years ago, Malin Parmar's research team was one of the first in the world to convert human skin cells directly into brain cells without passing the stem cell state. The discovery shocked the researchers and was perceived as almost impossible. The team is now approaching a point where the discovery is about to bear fruit on a wide scale. By following a new method that involves slightly changing the genetic code that triggers cell conversion, the researchers were able to multiply the production of disease-specific brain cells.

"Primarily, we inhibited a protein, REST, involved in establishing identity in cells that are not nerve cells. After limiting this protein's impact in the cells during the conversion process, we've seen completely different results. Since then, we've been playing around with changing the dosage of the other components in the previous method, which also proved effective. Overall, the efficiency is remarkable. We can now generate almost unlimited amounts of neurons from one skin biopsy", says Malin Parmar, professor of developmental and regenerative neurobiology at Lund University.

The video will load shortly

The increase in production will have far-reaching effects. The new volumes enable research projects that were simply not viable before. Among other things, it opens up research areas linked to new drug testing, the establishment of more accurate disease models and the development of diagnostics to detect the diseases at an earlier stage.

The new cells are not only able to imitate the disease but also the patient's age. By studying the cell in the culture dish, the researchers can now monitor the mechanisms of the disease in an "old" brain cell over time. Neurodegenerative diseases are commonly referred to as "aging brain diseases" and in order to understand them, we must better appreciate how the age specifically affects the course of the disease. The Lund researchers' discovery can hopefully contribute a crucial piece to the puzzle with regard to the connection between the onset of disease and cell aging, something which previous research based on animal experiments and stem cells has failed to provide.

"This takes us one step closer to reality, as we can now look inside the human neurons and see what goes on inside the cell in these diseases. If all goes well, this could fundamentally change the field of research, as it helps us better understand the real mechanisms of the disease. We believe that many laboratories around the world would like to start testing on these cells to get closer to the diseases", says Johan Jakobsson, leader of the molecular neurogenetics research group at Lund University.

Explore further: Researchers form new nerve cellsdirectly in the brain

The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments. A new report from researchers at Lund University in ...

Using human skin cells, University of California, Irvine neurobiologists and their colleagues have created a method to generate one of the principle cell types of the brain called microglia, which play a key role in preserving ...

Wellcome Trust Sanger Institute scientists and their collaborators at the University of Cambridge have created a new technique that simplifies the production of human brain and muscle cells - allowing millions of functional ...

Researchers at Karolinska Institutet have made significant progress in the search for new treatments for Parkinson's disease. By manipulating the gene expression of non-neuronal cells in the brain, they were able to produce ...

The first transplantation of stem cells in patients with Parkinson's disease is almost within reach. However, it remains a challenge for researchers to control stem cells accurately in the lab in order to achieve successful ...

The sex of animals frequently has an effect in biomedical research and therefore should be considered in the study of science, report scientists from the Wellcome Trust Sanger Institute and the International Mouse Phenotyping ...

When women undergo lumpectomies to remove breast cancer, doctors try to remove all the cancerous tissue while conserving as much of the healthy breast tissue as possible.

Your brain is armored. It lives in a box made of bones with a security system of vessels. These vessels protect the brain and central nervous system from harmful chemicals circulating in the blood. Yet this protection systemknown ...

New research overturns long-held views on a basic messaging system within living cells. Key cellular communication machinery is more regionally constrained within the cell than previously thought. The findings suggest new ...

Scientists used human pluripotent stem cells to generate human embryonic colons in a laboratory that function much like natural human tissues when transplanted into mice, according to research published June 22 in Cell Stem ...

The leading cause of acute gastroenteritis linked to eating raw seafood disarms a key host defense system in a novel way: It paralyzes a cell's skeleton, or cytoskeleton.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Go here to see the original:
Large-scale production of living brain cells enables entirely new research - Medical Xpress

Scientist-backed PAC endorses Dana Rohrabacher’s challenger – Salon

Republican Rep. Dana Rohrabacher of California is a well-known science denier, particularly when it comes to the issue of man-made climate change. In response,314 Action, a new PAC that exists to help elect scientists to public office, is officially endorsing a Democratic rival to opposeRohrabacher in his 2018 reelection campaign.

Dr. Hans Keirstead is aPhD neuroscientist, cancer doctor and former UC Irvine School of Medicine professor, as well as the first non-incumbent endorsement that 314 Action has made.

Scientists are trained to follow the facts no matter where they lead, Keirstead toldSalon through email. Many times, a hypothesis does not get borne out by the facts. Science isnt about opinions or how you feel. Its about the pursuit of truth, and as a scientist, I have learned the value of real evidence and data. I believe my career developing successful, breakthrough cancer treatments through stem cell research will speak to people.

Keirsteads work on stem cell research has helped with treatment of various cancers, multiple sclerosis, and Lou Gehrigs disease, among other medical conditions.

Rohrabacher claims that he loves science,a fact that Keirstead insists is only the first step toward actually using science in a responsible way as a policymaker.

Understanding how science effects every day Americans lives? Thats where a policy maker who understands science makes their impact, Keirstead explained. I have seen firsthand how it can save lives by investing in medical research that leads to curing cancer or changing lives by providing jobs and infrastructure to a community like Orange County.

TheTrump administrations budget is a war on facts that the scientific community knows all about, saidShaughnessy Naughton, a chemist who founded 314 Action.

Whether its his massive cuts to research budgets, his views on climate change, vaccines, the decision to pull out of the Paris Agreement, or countless others, science is under attack right now. While we dont have a set criteria of policies for candidates who come to us, support for research funding and a recognition of the urgency with which we need to act on combating climate change.

Compare that with what is happening in Washington today with Trumps budget proposal,Keirstead added. They are slashing funding for the National Institute of Health and doubling user fees on small businesses. That has a direct effect on the work I and many in the medical field do. I guarantee you that if our research labs fees were doubled, my cancer treatment would not have gone to clinical trials. We need representatives who understand the direct consequences of their proposals and, sadly, Im not convinced many do.

It remains to be seen whether Naughton and Keirsteads support for reason can triumph not only in the laboratory, but in voting booths as well.

Go here to see the original:
Scientist-backed PAC endorses Dana Rohrabacher's challenger - Salon

Stem Cell Stem Cell Treatments by Clinic 42

Home Version 10 topcatt 2016-10-03T01:15:08+00:00

Stem cells are tiny progenitor cells. They have the potential to recognise tissue injury and repair injured cells. In the right environment, these stem cells can change (differentiate) into bone, cartilage, muscle, fat, collagen, neural tissue, blood vessels and even some organs. Stem cells may also affect healing by secreting special chemical messengers that repair damaged tissue. Adult stem cells appear to be particularly effective in improving painful joints, repairing cartilage and ligaments and even painful conditions along the spine. There are many clinical trials with stem cells going on right now which suggest a very broad and exciting potential for Stem Cells in Advancing Medicine. At Clinic 42, we assess each case on its merits as to suitability for treatment. Please use our online application formto submit an application for selection to undergo this advanced new therapy, or contact usto learn more.

Clinic 42 is an Advanced Cosmetic Medical Clinic based in Epsom, Auckland. We provide the most Advanced and Scientifically Proven Treatments Delivered Under the Careful Guidance of Our Doctors.

Read more:
Stem Cell Stem Cell Treatments by Clinic 42

Mum of Corrie McKeague reveals how close police are to finding her son – Cambridge News

The mum of missing airman Corrie McKeague has revealed how close police are to finding her son.

Police have been searching for the 23-year-old at a landfill site in Milton, Cambridgeshire, since March, after he went missing on a night out in Bury St Edmunds on September 24 last year.

Officers believe that the 23-year-old was dumped by a bin lorry into the landfill site.

Nicola Urquhart, 48, believes that Corrie could be found 'literally tomorrow' if he is in the landfill.

On the Find Corrie Facebook page, she wrote: "The police will continue to search this area [the cell] of the landfill until they either find Corrie or the rubbish starts clearly and consistently showing it has gone back too far in date ranges.

"This is why no completion date can be given as this is reviewed daily/weekly."

She added: "Rubbish is still being found with dates and locations to show they are still in the correct area so they are slowly working their way back to the edges of the entire cell.

"Due to the rubbish that is being found, if Corrie is in this landfill he could literally be found tomorrow."

Nicola also wanted to clarify what the 'cell' actually represented, as previously she said that there was a smaller area left to search.

The mother uses the analogy of a football cut in half and filled with rubbish.

"This is what I understand to be the cell, however the reality is if you were to get a medicine ball and cut that in half and place the football inside it, it is actually the edges of the medicine ball that's the edges of the entire cell.

"The police have searched through the rubbish in the football. To empty the football shaped area they were able to say this may take about 10 weeks (which it roughly did).

"And as they got to the edges they could see the dates of the rubbish was going back far too early, prior to when Corrie disappeared.

"On one side however, the rubbish is still being found with dates and locations to show that they are still in the correct area, so they are slowly working their way back to the edges of the entire cell (the edges of the medicine ball).

"So the area they are searching is still the same depth as the middle of the cell as they are no where near the edges yet which means this will take far longer to search than I first understood."

Corrie was last seen on CCTV at 3.24am walking into a refuse area behind a Greggs in Bury St Edmunds.

Police believe the only way that the 23-year-old could have left that area without being spotted by CCTV is through a bin lorry that entered the refuse area to take rubbish from a Biffa bin only hours later.

The airman's mobile was tracked travelling in a similar direction to a bin lorry's route.

The bin lorry's weight was also found to have carried rubbish heavy enough to have contained Corrie's body.

Police and the family are confident that the airman is in the landfill.

Specialists have sifted through more than 5000 tonnes of rubbish so far.

See the original post here:
Mum of Corrie McKeague reveals how close police are to finding her son - Cambridge News

Takeda preps for EU Crohn’s disease stem cell therapy manufacture – BioPharma-Reporter.com

Takeda says it is assessing manufacturing options ahead of potential European approval later this year of the Crohns disease stem cell therapy licensed from TiGenix.

Following its acceptance for review by the European Medicines Agency (EMA), Takeda and TiGenix announced this week Swissmedic has accepted for review the file for compound Cx601, an allogeneic expanded adipose-derived stem cell (eASC) therapy for the treatment of complex perianal fistulas in patients with Crohns disease.

The therapy is being made from TiGenix site in Madrid, Spain but CEO Eduardo Bravo told Biopharma-Reporter its partner Takeda which holds the rights for Cx601 in non-US markets following a licensing agreement inked last year will take responsibility for its manufacture from 2021 from a purpose built manufacturing facility in Europe.

Takeda spokesman Luke Willats told this publication: After a transition period for technology transfer during which TiGenix will manufacture Cx601, Takeda will assume responsibility for manufacturing the compound.

But while Willats added the firm is exploring how itcan best meet manufacturing responsibilities for Cx601 following a potential European Commission (EC) approval decision for the compound in 2017, he could not comment further on specific plans or CAPEX investments.

The Japanese pharma firm has its European headquarters in Switzerland, with production sites in Austria, Belgium, Denmark, Estonia, Germany, Ireland, Italy, Norway, Poland and Russia.

Fat chance

Cx601 is produced by TiGenix in plastic flasks in incubators at a one-litre scale, using stem cells taken from healthy volunteers who have undergone liposuction for cosmetic reasons, Bravo told us.

The fat gets sent to our facility in Madrid and is processed to extract the stem cells, which account for about 2% of the material. These are placed in plastic flasks with serum to multiply the number. This is repeated until there is a large population and then the cells are frozen, creating the master cell bank (MCB).

According to Bravo, one liposuction when expanded produces upwards of 360 billion cells, enough to treat 2,400 patients.

While TiGenix is considering using bioreactors for its future pipeline, it will continue making the product as it does now due to not needing to increase volume and the challenges of making production changes in the middle or end of development.

For cell therapies, the process defines the product. Anything you change could change the cells themselves, effectively changing the product.

US deal with Lonza

TiGenix holds the US rights to Cx601 and is discussing with the US Food and Drug Administration (FDA) whether it can file using EMA data, something Bravo said would be decided in the next six-to-eight months.

US trial material will be produced by TiGenixs contract manufacturing organisation (CMO) Lonza , which is undergoing tech transfer at its site in Maryland.

But looking ahead to commercialisation, Bravo said it is not yet decided whether we continue using a CMO or build our own [US] facility.

Read this article:
Takeda preps for EU Crohn's disease stem cell therapy manufacture - BioPharma-Reporter.com

‘Little Frankenstein,’ conceived so Minnesota doctors could save sister, is now a happy teen – Minneapolis Star Tribune

Richard Sennott, Star Tribune file During a family portrait in 2000, Molly Nash gives her 4-week-old brother, Adam, a kiss. Molly Nash received some umbilical blood from her brother, saving her from a fatal genetic disease.

Adam Nash was dubbed Little Frankenstein by the New York Post in 2000 because he was conceived via in vitro fertilization specifically so doctors at the University of Minnesota could collect stem cells from his umbilical cord blood to save his sister, Molly.

Today, back home in Colorado, Adam has a drivers license and helps disabled children ski. His sister once weeks from death due to a condition called Fanconi anemia is debating whether to focus on oceanography or graphic design in college. And IVF to produce an ideal child for a siblings stem cell transplant is common, albeit with lingering ethics concerns.

A squirrelly trio of teens is vindication for Adams mother, Lisa Nash, who felt the weight of the ethical questions when the Us Dr. John Wagner suggested IVF in 1995.

See the rest here:
'Little Frankenstein,' conceived so Minnesota doctors could save sister, is now a happy teen - Minneapolis Star Tribune

Chronic Lyme Disease Isn’t a Real Diagnosis. So Why Are Doctors Prescribing Risky Treatment for It? – Health.com

Unproven treatments for symptoms sometimes described as chronic Lyme disease can be dangerous and even deadly, according to a recent report from the Centers for Disease Control and Prevention (CDC).

The paper, published in Morbidity and Mortality Weekly, documents several cases from recent years in which long courses of IV antibiotics and other supposed remedies led to septic shock and serious bacterial infections. Whats more, the authors say, theres no evidence these treatments actually help the patients who seek them out.

Chronic Lyme disease is not a medical diagnosis, and the CDC recommends against using the term at all. Still, some doctors use it to describe situations in which a confirmed case of Lyme disease is treated, but the patient still has lingering symptoms. This condition, which is estimated to occur in 10% to 20% of Lyme disease cases, is technically called post-treatment Lyme disease syndrome, or PTLDS.

RELATED: 8 Celebrities Who've Struggled With Lyme Disease

Some doctors also use the term chronic Lyme disease to diagnose patients who have otherwise unexplained symptoms (including joint and muscle aches, fatigue, and neurological problems) but no actual evidence they were ever infected with Lyme in the first place.

When Lyme disease is caught early, within weeks of the first symptoms after a tick bite, most people recovery completely after a short course of oral antibiotics. For cases that have gone untreated for longer, a four-week course of IV antibiotics might be necessary.

If a persons symptoms still dont go away after that, though, thats where confusion often sets in. Research onPTLDS is ongoing, and the cause of these symptoms is still unknown. Experts believe that some of these symptoms may be caused by residual damage to tissues and the immune system, and some may not be related to Lyme disease at all.

But one thing Lyme researchers know for sure is that longer courses of antibiotics do not lead to meaningful improvements; at least five randomized, placebo-controlled studies have shown this much. Nevertheless, some doctors still prescribe themfor months or even years, says reportco-author Christina Nelson, MD, medical epidemiologist for the CDC.

Other doctors or alternative-medicine practitioners recommend other unproven remedieslike IV infusions of peroxide, immunoglobulin therapy, hyperbaric oxygen therapy, electromagnetic frequency treatments, garlic supplements, colloidal silver, and stem cell transplants.

Weve known about cases like these for quite some time, but anecdotally, we did seem to be hearing about them more frequently, says Dr. Nelson. A 2015 studynoted a 50%increase in long-course antibiotic therapies prescribed for Lyme disease between2004 to2006 and2010 to2012.

Doctors who provide these treatments "dont typically follow the most commonly recommended treatments and the evidence-based guidelines, she says, and they may diagnose Lyme disease even if blood tests are negative. Most general practitioners and infectious disease physicians would not provide this type of care.

RELATED: 5 Ways to Tell if You Need an Antibiotic

Besides being unproven, these treatments can be dangerous, says Dr. Nelson. In thepaper, she and her co-authors describe a woman in her 30s who received a chronic Lyme diagnosis and, when oral antibiotics didnt help her symptoms, was given three weeks of IV antibiotics.

She became sick and eventually died from septic shock. In another case of antibiotic-related septic shock, an adolescent girl survived but required several weeks of treatment in a hospital intensive-care unit.

Antibiotics work well for certain infections, but the use of long-term IV medicineswhich require an in-dwelling catheter (often called a PICC line) to be inserted in the skincan actually expose people to other dangerous bugs. Other bacteria from the skin or from the hospital or wherever can enter through that IV line or attach to that IV line, and the drugs may not be effective against them. says Dr. Nelson.

In another case described in the paper, a woman in her 40s tested positive for Lyme disease but didnt feel better after four weeks of oral antibiotics. She received various IV antibiotic treatments over the next year and eventually developed back painwhich a scan revealed to be a serious bone infection.

To get our best wellnesstips delivered to you inbox, sign up for theHealthy Living newsletter

Another big concern with diagnosis of chronic Lyme disease is that the actual cause of a persons symptoms could go ignored or untreated. This was the case for a 50-something woman diagnosed with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. When she sought a second opinion, she was told she had chronic Lyme disease along with other tick-borne illnesses, babesiosis and Rocky Mountain Spotted Fever.

The woman was treated with herbs, homeopathic remedies, and antibiotic, antifungal, and antiviral drugs, and eventually developed an intestinal infection that caused severe cramps and diarrhea for more than two years. She was on this cocktail of medications for months and months, and it set her up for the bad bacteria in her gut to take over and overpower the good bacteria, says Dr. Nelson.

Dr. Nelson says the woman, who eventually died from complications of ALS, was simply trying to make sure she had pursued every possible treatment option for her symptoms. She had gotten this devastating diagnosis, and understandably it can be hard to accept, she says. She wanted to make sure she was doing everything she could, and unfortunately this was a very tragic case.

RELATED: 18 Important Facts You Must Know About Ticks

These are just a few of the cases reported to the CDC in recent years, says Dr. Nelson, but they bring to light the very real risks associated with these types of unproven treatments.

The actual number of people who undergo these types of treatmentsor who develop complications from themis unknown, the authors wrote. They hope that more research can be done to better quantify this phenomenon, and to help more doctors and patients understand the dangers involved and make informed decisions about their care.

Read this article:
Chronic Lyme Disease Isn't a Real Diagnosis. So Why Are Doctors Prescribing Risky Treatment for It? - Health.com

Jonathan Pitre still ailing as doctors search for answers | Ottawa … – Ottawa Citizen

Photo of Jonathan Pitre and his mother, Tina Boileau, taken in Minnesota. Tina Boileau / -

Doctors in a Minnesota hospital continue to search for answers to a mysterious infection that has left Jonathan Pitre feverish, nauseated and short of breath.

Pitre, 17, of Russell, has been in the University of Minnesota Masonic Childrens Hospital for the past two weeks, suffering from an array of complications more two months after his stem cell transplant. Doctors are also trying to adjust his medications to better deal with his increased pain levels.

Hes having a tough run, said his mother, Tina Boileau, and I really dont know when it will get better.

The teenager suffers from a severe form of epidermolysis bullosa (EB), a painful and progressive skin disease that has left deep, open wounds on his body.

Last week, Pitres face and neck became swollen in response to what doctors believed was some kind of viral infection. That swelling has been brought under control, but a battery of tests has yet to reveal the source of the infection, which continues to cause problems.

Pitres breathing is laboured and hes running a high-grade fever of about 104 F (40 C); he has also developed bleeding and painful sores in his mouth.

We still have no idea what were dealing with, said Boileau. Its frustrating because Im at the point where it would be nice to see that all that Jonathan has gone through has been worth it.

Doctors are monitoring Pitre for graft-versus-host-disease (GVHD), but all of his tests have so far been inconclusive.Anyone who receives stem cells from another person is at risk of developing GVHD, a condition in which the donors white blood cells turn on the patients own tissues and attack them as foreign. It can range from mild to life-threatening.

About one-third of the almost 50 EB patients who have had a stem cell transplant at the Masonic Childrens Hospital have experienced the condition.

Pitre checked back into hospital earlier this month just three days after being released following a stem cell transplant that had successfully taken root in his bone marrow. Bone marrow stem cells produce most of the bodys blood cells, and are responsible for arming its immune system.

Pitre has been in Minnesota since mid-February to undergo the transplant, his second. The first ended in disappointment on Thanksgiving Day last year.

Tests show Pitres latest transplant remains fully engrafted, and there are signs that it has started to improve the condition of his skin.

The rest is here:
Jonathan Pitre still ailing as doctors search for answers | Ottawa ... - Ottawa Citizen